Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 1/20 | 0.40 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | USP2 | O75604 | 3/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 7/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.34 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25708743 | 1.00 | CYP4F2 (0.40) | CYP4F2CYP4A11SMN1; SMN2USP2CYP2D6 | |
| SCHEMBL23512796 | 0.90 | CYP2D6 (0.39) | CYP4F2CYP4A11SMN1; SMN2USP2CYP2D6 | |
| SCHEMBL26053291 | 0.89 | CYP1A2 (0.39) | SMN1; SMN2USP2CYP2D6ALDH1A1CYP2C19 | |
| SCHEMBL24615831 | 0.85 | SMN1; SMN2 (0.45) | SMN1; SMN2ALDH1A1CYP1A2TDP1 | |
| SCHEMBL12372529 | 0.80 | USP2 (0.42) | CYP4F2CYP4A11SMN1; SMN2USP2 | |
| SCHEMBL13819676 | 0.79 | SMN1; SMN2 (0.39) | CYP4F2CYP4A11SMN1; SMN2USP2CYP2D6 | |
| SCHEMBL13819904 | 0.79 | SMN1; SMN2 (0.39) | CYP4F2CYP4A11SMN1; SMN2USP2CYP2D6 | |
| SCHEMBL5566107 | 0.78 | CYP2D6 (0.36) | SMN1; SMN2USP2CYP2D6ALDH1A1CYP2C19 | |
| SCHEMBL15716997 | 0.76 | USP2 (0.36) | SMN1; SMN2USP2CYP2D6ALDH1A1CYP2C19 | |
| SCHEMBL12284806 | 0.74 | CYP2D6 (0.39) | CYP4F2CYP4A11SMN1; SMN2CYP2D6ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230265090-A1 | QUINAZOLINE COMPOUND | MEDSHINE DISCOVERY INC. (CN) | 2023-08-24 | — | — | US | disclosed |
| US-20230265090-A1 | QUINAZOLINE COMPOUND | MEDSHINE DISCOVERY INC. (CN) | 2023-08-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230265090-A1 | QUINAZOLINE COMPOUND | ABCG2, CYP3A7, ABL1 | CYP4F2 66/4885CYP4A11 129/4885SMN1; SMN2 2114/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.